###begin article-title 0
Diagnostic algorithm for papillary urothelial tumors in the urinary bladder
###end article-title 0
###begin p 1
###xml 1185 1186 1185 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 964 972 <span type="species:ncbi:9606">patients</span>
###xml 1090 1098 <span type="species:ncbi:9606">patients</span>
Papillary urothelial neoplasms with deceptively bland cytology cannot be easily classified. We aimed to design a new algorithm that could differentiate between these neoplasms based on a scoring system. We proposed a new scoring system that enables to reproducibly diagnose non-invasive papillary urothelial tumors. In this system, each lesion was given individual scores from 0 to 3 for mitosis and cellular thickness, from 0 to 2 for cellular atypia, and an additional score for papillary fusion. These scores were combined to form a summed score allowing the tumors to be ranked as follows: 0-1 = UP, 2-4 = low malignant potential (LMP), 5-7 = low-grade transitional cell carcinoma (TCC), and 8-9 = high-grade TCC. In addition to the scoring system, ancillary studies of MIB and p53 indexes with CK20 expression pattern analyses were compared together with clinical parameters. The MIB index was strongly correlated with disease progression. Four of the 22 LMP patients (18.2%) had late recurrences, two of these four (9.1%) had progression to low-grade carcinoma. The MIB index for LMP patients was strongly associated with recurrence (recurrence vs. non-recurrence, 16.5 vs. 8.1, p < 0.001). The proposed scoring system could enhance the reproducibility to distinguish papillary urothelial neoplasms.
###end p 1
###begin title 2
Keywords
###end title 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
According to the 1998 World Health Organization/International Society of Urological Pathology (WHO/ISUP) [7, 23], the 1999 WHO blue book [15], and 2004 WHO blue book [12], papillary urothelial neoplasms (PUNs) have been categorized as urothelial papilloma (UP), inverted papilloma (IP), papillary urothelial neoplasm of low malignant potential (PUNLMP), low-grade papillary urothelial carcinoma (LGPUC), and high-grade papillary urothelial carcinoma (HGPUC). The main aim of the 1998 WHO/ISUP classification guidelines was to develop a universally accepted and reproducible classification system. However, the reproducible classification and diagnostic criteria between non-invasive superficial PUN, a constellation of well-known papillary tumors of low progression incidence, remains in dispute. In particular, PUNLMP terminology has been the main point of discussion in the field since the introduction of the 1998 WHO/ISUP classification system.
###end p 4
###begin p 5
###xml 267 268 267 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 455 456 455 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 830 831 830 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 1137 1139 1137 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 1141 1143 1141 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 1277 1278 1277 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 1280 1282 1280 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 1283 1285 1283 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
UP or IP, whether exophytic or inverted, is well defined because it usually presents as a small single mass. PUNLMP is defined as papillary urothelial tumors which resemble exophytic UP, except for an increased cellular proliferation that exceeds a normal thickness [7, 12, 15, 23]. LGPUC is defined as complex papillary fronds with easily recognizable architectural and cytological variations. Tumors with moderate-to-marked atypia are defined as HGPUC [7, 12, 15, 23]. However, from the pathologic viewpoint, the diagnostic boundary between stage 0 (Ta) LGPUC and the non-carcinoma group is vague. By definition, the critical point for deciphering between PUNLMP and UP is the identification of layers exceeding an accepted urothelial thickness. This step can be very subjective and confusing, which regard to the section axes [6]. Moreover, architectural and cytologic atypia favor a LGPUC classification over PUNLMP or UP classification and are even less reproducible. Through survey of a consensus trial of papillary urothelial tumors, a severe discrepancy was observed in PUNLMP by even the most experienced urologic pathologists [16, 23]. Thus, the clinical significances and biological differences in PUNLMP are still inconclusive due to ambiguous diagnostic criteria [5, 17-19].
###end p 5
###begin p 6
We designed an algorithm based on the scoring system defined by several histopathological findings. For confirmation, we surveyed the clinical manifestation and recent 5-year follow-up data on 175 papillary urothelial tumors. In addition, we also assessed ancillary studies of MIB and p53 indexes with CK20 expression pattern analysis. While both ends of the MIB and p53 index spectrums were easily categorized as UP and LGPUC, cases within the shaded zone were reviewed clinically and re-assessed by our scoring system.
###end p 6
###begin title 7
Materials and methods
###end title 7
###begin title 8
Materials
###end title 8
###begin p 9
One hundred seventy-five cases were selected from the medical records and archival slides. These cases were selected from a large collection of papillary urothelial tumors in Urologic Oncology Files of Yonsei University College of Medicine since 1990.
###end p 9
###begin p 10
###xml 204 211 <span type="species:ncbi:9606">patient</span>
###xml 416 424 <span type="species:ncbi:9606">patients</span>
###xml 578 586 <span type="species:ncbi:9606">patients</span>
Demographic data with regard to age, sex, the site involved, tumor number, size, time to recurrence, frequency of recurrence, progression, associated malignancy, and survival time were obtained from each patient's medical records. The time of recurrence was calculated from the time from a complete response (no evidence of disease) to the time of the first evidence of tumor recurrence at the latest follow-up. All patients underwent transurethral resection (TUR) of the bladder tumor. After the initial TUR was performed at 6-month interval for 2 years and yearly thereafter, patients did not receive any additional intravesical treatment until the first recurrence.
###end p 10
###begin p 11
###xml 148 159 <span type="species:ncbi:9606">participant</span>
###xml 343 355 <span type="species:ncbi:9606">participants</span>
All cases were independently reanalyzed by seven pathologists specialized in urological pathology, in the first round of the consensus review. Each participant rendered a diagnosis after a prior training session based on the 2004 WHO classification. After completing the first round, all cases were reviewed with our new scoring system by all participants of the present study.
###end p 11
###begin title 12
Scoring system
###end title 12
###begin p 13
###xml 229 230 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 521 527 521 527 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 586 587 586 587 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 804 805 804 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 879 880 879 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3</italic>
###xml 955 956 955 956 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 966 967 966 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 1025 1026 1025 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 1093 1094 1093 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3</italic>
###xml 1136 1137 1136 1137 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1156 1157 1156 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">0</italic>
###xml 1222 1223 1222 1223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 1304 1305 1304 1305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 527 1410 527 1410 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="14">Histopathological findings of papillary urothelial tumors. <bold>a</bold> Thickness of layers. Each number represents the corresponding score: 0 means a thickness less than seven layers with intact umbrella cells, 1 means a thickness less than seven layers with the loss of umbrella cells, <italic>2</italic> means a thickness more than seven layers with intact umbrella cells, and <italic>3</italic> means a thickness more than seven layers with the loss of umbrella cells. <bold>b</bold> Mitosis. <italic>1</italic> means a few mitoses less than five per high power field, <italic>2</italic> means mitotic index between five and ten mitoses per ten HPF, and <italic>3</italic> means more than ten mitoses per ten HPF. <bold>c</bold> Cytologic atypia. <italic>0</italic> Atypia restricted to the surface is not considered true atypia. <italic>1</italic> Diffuse cellular atypia in a random fashion, but with a mild degree is score 1. <italic>2</italic> Diffuse cellular atypia in a random fashion and a moderate to severe degree of atypia is defined score 2</p>
###xml 527 1410 527 1410 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="14">Histopathological findings of papillary urothelial tumors. <bold>a</bold> Thickness of layers. Each number represents the corresponding score: 0 means a thickness less than seven layers with intact umbrella cells, 1 means a thickness less than seven layers with the loss of umbrella cells, <italic>2</italic> means a thickness more than seven layers with intact umbrella cells, and <italic>3</italic> means a thickness more than seven layers with the loss of umbrella cells. <bold>b</bold> Mitosis. <italic>1</italic> means a few mitoses less than five per high power field, <italic>2</italic> means mitotic index between five and ten mitoses per ten HPF, and <italic>3</italic> means more than ten mitoses per ten HPF. <bold>c</bold> Cytologic atypia. <italic>0</italic> Atypia restricted to the surface is not considered true atypia. <italic>1</italic> Diffuse cellular atypia in a random fashion, but with a mild degree is score 1. <italic>2</italic> Diffuse cellular atypia in a random fashion and a moderate to severe degree of atypia is defined score 2</p></caption>
###xml 1410 1410 1410 1410 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="428_2008_585_Fig1_HTML" id="MO1"/>
###xml 521 1410 521 1410 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="14">Histopathological findings of papillary urothelial tumors. <bold>a</bold> Thickness of layers. Each number represents the corresponding score: 0 means a thickness less than seven layers with intact umbrella cells, 1 means a thickness less than seven layers with the loss of umbrella cells, <italic>2</italic> means a thickness more than seven layers with intact umbrella cells, and <italic>3</italic> means a thickness more than seven layers with the loss of umbrella cells. <bold>b</bold> Mitosis. <italic>1</italic> means a few mitoses less than five per high power field, <italic>2</italic> means mitotic index between five and ten mitoses per ten HPF, and <italic>3</italic> means more than ten mitoses per ten HPF. <bold>c</bold> Cytologic atypia. <italic>0</italic> Atypia restricted to the surface is not considered true atypia. <italic>1</italic> Diffuse cellular atypia in a random fashion, but with a mild degree is score 1. <italic>2</italic> Diffuse cellular atypia in a random fashion and a moderate to severe degree of atypia is defined score 2</p></caption><graphic position="anchor" xlink:href="428_2008_585_Fig1_HTML" id="MO1"/></fig>
Well-known parameters used in different point systems were adopted for the new scoring scheme. The most critical, highly reproducible findings including thickness of layers and mitosis with cytologic atypia were depicted in Fig. 1. According to consensus rate between peer reviewers, relevant impact was given differently. Three points were given in the best reproducible criteria, thickness of layers and mitosis, and cytologic atypia. One point was given in the parameter with wide range of variation, papillae fusion. Fig. 1Histopathological findings of papillary urothelial tumors. a Thickness of layers. Each number represents the corresponding score: 0 means a thickness less than seven layers with intact umbrella cells, 1 means a thickness less than seven layers with the loss of umbrella cells, 2 means a thickness more than seven layers with intact umbrella cells, and 3 means a thickness more than seven layers with the loss of umbrella cells. b Mitosis. 1 means a few mitoses less than five per high power field, 2 means mitotic index between five and ten mitoses per ten HPF, and 3 means more than ten mitoses per ten HPF. c Cytologic atypia. 0 Atypia restricted to the surface is not considered true atypia. 1 Diffuse cellular atypia in a random fashion, but with a mild degree is score 1. 2 Diffuse cellular atypia in a random fashion and a moderate to severe degree of atypia is defined score 2
###end p 13
###begin p 14
###xml 59 60 59 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 277 278 277 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 352 353 352 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3</italic>
###xml 428 429 428 429 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 439 440 439 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 498 499 498 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 566 567 566 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3</italic>
###xml 609 610 609 610 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 629 630 629 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">0</italic>
###xml 695 696 695 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 777 778 777 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
Histopathological findings of papillary urothelial tumors. a Thickness of layers. Each number represents the corresponding score: 0 means a thickness less than seven layers with intact umbrella cells, 1 means a thickness less than seven layers with the loss of umbrella cells, 2 means a thickness more than seven layers with intact umbrella cells, and 3 means a thickness more than seven layers with the loss of umbrella cells. b Mitosis. 1 means a few mitoses less than five per high power field, 2 means mitotic index between five and ten mitoses per ten HPF, and 3 means more than ten mitoses per ten HPF. c Cytologic atypia. 0 Atypia restricted to the surface is not considered true atypia. 1 Diffuse cellular atypia in a random fashion, but with a mild degree is score 1. 2 Diffuse cellular atypia in a random fashion and a moderate to severe degree of atypia is defined score 2
###end p 14
###begin p 15
###xml 1008 1009 1008 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
Because increased cellular proliferation exceeding to seven layers is the minimal criteria for a score, indicating a more progressive disease than PUNLMP, this particular criteria should be emphasized. Our general rule was to judge areas of the section where the papillae are sectioned perpendicular to the surface and basement membrane and thus include the central fibrovascular stalk while avoiding areas of oblique or longitudinally cut. However, despite unequivocal LGPUC, the loss of umbrella cells leads to a section that is thinner than seven layers. The scoring criteria for cellular thickness in the sample was as follows: 0 point if all fronds had less than seven layers and intact umbrella cells were present, 1 point if any fronds had less than seven layers but no obvious umbrella cells were present, 2 points if samples had more than one frond with more than seven layers and intact umbrella cells, and 3 points if any fronds had more than seven layers and no umbrella cells were present (Fig. 1a).
###end p 15
###begin p 16
###xml 139 140 139 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
Mitotic figures were assessed by recording the total numbers from ten high power (x400) fields (HPF) selected at random in each case (Fig. 1b). If more than ten mitoses/ten HPF were identified, 3 points were given. In case between five and ten mitosis/ten HPF, 2 points were given. In case with mitotic index less than 5/10 HPF, 1 point was given. Samples that did not show any mitosis were given a 0 score.
###end p 16
###begin p 17
###xml 384 385 384 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 656 657 656 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 1132 1138 1132 1138 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 1209 1210 1209 1210 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1271 1272 1271 1272 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1281 1289 1281 1289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">asterisk</italic>
###xml 1316 1322 1316 1322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">circle</italic>
###xml 1346 1347 1346 1347 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1394 1395 1394 1395 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1433 1441 1433 1441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">asterisk</italic>
###xml 1474 1480 1474 1480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">circle</italic>
###xml 1483 1484 1483 1484 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 1544 1552 1544 1552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">asterisk</italic>
###xml 1570 1576 1570 1576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">circle</italic>
###xml 1138 1577 1138 1577 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="18">Atypia in surface cells of urothelial papilloma or inverted papilloma. <bold>a</bold> Polypoid mass with an inverted pattern of urothelial nests. <bold>b</bold> Atypia (<italic>asterisk</italic>) is noted in the surface (<italic>circle</italic>) of the inverted nest. <bold>c</bold> Atypical cells are not immunoreactive to MIB. <bold>d</bold> Syncytial changes of atypical cells (<italic>asterisk</italic>) are restricted to the surface (<italic>circle</italic>). <bold>e</bold> MIB is scattered, but not expressed in the atypical cells (<italic>asterisk</italic>) of the surface (<italic>circle</italic>)</p>
###xml 1138 1577 1138 1577 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="18">Atypia in surface cells of urothelial papilloma or inverted papilloma. <bold>a</bold> Polypoid mass with an inverted pattern of urothelial nests. <bold>b</bold> Atypia (<italic>asterisk</italic>) is noted in the surface (<italic>circle</italic>) of the inverted nest. <bold>c</bold> Atypical cells are not immunoreactive to MIB. <bold>d</bold> Syncytial changes of atypical cells (<italic>asterisk</italic>) are restricted to the surface (<italic>circle</italic>). <bold>e</bold> MIB is scattered, but not expressed in the atypical cells (<italic>asterisk</italic>) of the surface (<italic>circle</italic>)</p></caption>
###xml 1577 1577 1577 1577 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="428_2008_585_Fig2_HTML" id="MO2"/>
###xml 1132 1577 1132 1577 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="18">Atypia in surface cells of urothelial papilloma or inverted papilloma. <bold>a</bold> Polypoid mass with an inverted pattern of urothelial nests. <bold>b</bold> Atypia (<italic>asterisk</italic>) is noted in the surface (<italic>circle</italic>) of the inverted nest. <bold>c</bold> Atypical cells are not immunoreactive to MIB. <bold>d</bold> Syncytial changes of atypical cells (<italic>asterisk</italic>) are restricted to the surface (<italic>circle</italic>). <bold>e</bold> MIB is scattered, but not expressed in the atypical cells (<italic>asterisk</italic>) of the surface (<italic>circle</italic>)</p></caption><graphic position="anchor" xlink:href="428_2008_585_Fig2_HTML" id="MO2"/></fig>
Although cellular atypia can be another parameter that can distinguish benign or malignant tumors, caution should be taken when interpreting this criterion because the cellular distribution for this characteristic is variable. If the cellular atypia is restricted to superficial cells, this is less significant with regard to determining whether a sample is benign or malignant (Fig. 2). In our scoring system, samples with randomly and frequently distributed cellular atypia with moderate to severe degree were given 2 points. One point was assigned to samples with randomly distributed mild atypia. Samples with no pleomorphism were given 0 scores (Fig. 1c). The moderate to severe atypia are defined to be easily recognized in low power field, whereas mild atypia is observed as slightly variable nuclear size and clumping of chromatin in high power field. Cell morphology could be another additive feature that can distinguish benign and malignant tumors, but not included in this category. Spindle cells frequently appear in the benign cases with a gradual transition to epithelioid cells occasionally as the tumor progresses. Fig. 2Atypia in surface cells of urothelial papilloma or inverted papilloma. a Polypoid mass with an inverted pattern of urothelial nests. b Atypia (asterisk) is noted in the surface (circle) of the inverted nest. c Atypical cells are not immunoreactive to MIB. d Syncytial changes of atypical cells (asterisk) are restricted to the surface (circle). e MIB is scattered, but not expressed in the atypical cells (asterisk) of the surface (circle)
###end p 17
###begin p 18
###xml 71 72 71 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 133 134 133 134 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 143 151 143 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">asterisk</italic>
###xml 178 184 178 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">circle</italic>
###xml 208 209 208 209 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 256 257 256 257 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 295 303 295 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">asterisk</italic>
###xml 336 342 336 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">circle</italic>
###xml 345 346 345 346 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 406 414 406 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">asterisk</italic>
###xml 432 438 432 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">circle</italic>
Atypia in surface cells of urothelial papilloma or inverted papilloma. a Polypoid mass with an inverted pattern of urothelial nests. b Atypia (asterisk) is noted in the surface (circle) of the inverted nest. c Atypical cells are not immunoreactive to MIB. d Syncytial changes of atypical cells (asterisk) are restricted to the surface (circle). e MIB is scattered, but not expressed in the atypical cells (asterisk) of the surface (circle)
###end p 18
###begin p 19
Another mechanism for distinguishing papillary urothelial tumors is by assessing architectural atypia. Because papillary fusion and branching is an easily recognized and fairly reproducible finding, a maximum of 1 point was given when this characteristic was observed. Unequivocal papillary fusion was given 1 point, and no branching or fused papillae was given 0 point. Although the palisading basal layer is another clue to polarity preservation, it is not definitely diagnostic. However, we experienced this feature as a strong supportive finding with approaching to the specific diagnosis of PUNLMP.
###end p 19
###begin p 20
###xml 49 50 49 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 240 247 240 247 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 247 304 247 304 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="21">Diagnostic scoring system for papillary urothelial tumors</p>
###xml 247 304 247 304 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="21">Diagnostic scoring system for papillary urothelial tumors</p></caption>
###xml 304 313 304 313 <th xmlns:xlink="http://www.w3.org/1999/xlink">Variables</th>
###xml 313 321 313 321 <th xmlns:xlink="http://www.w3.org/1999/xlink">Features</th>
###xml 321 326 321 326 <th xmlns:xlink="http://www.w3.org/1999/xlink">Score</th>
###xml 304 326 304 326 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>Variables</th><th>Features</th><th>Score</th></tr>
###xml 304 326 304 326 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th>Variables</th><th>Features</th><th>Score</th></tr></thead>
###xml 326 333 326 333 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="4">Mitosis</td>
###xml 333 343 333 343 <td xmlns:xlink="http://www.w3.org/1999/xlink">No mitosis</td>
###xml 343 344 343 344 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0</td>
###xml 326 344 326 344 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="4">Mitosis</td><td>No mitosis</td><td char="." align="char">0</td></tr>
###xml 344 353 344 353 <td xmlns:xlink="http://www.w3.org/1999/xlink">&lt;5/10 HPF</td>
###xml 353 354 353 354 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1</td>
###xml 344 354 344 354 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&lt;5/10 HPF</td><td char="." align="char">1</td></tr>
###xml 354 365 354 365 <td xmlns:xlink="http://www.w3.org/1999/xlink">5&#8211;10/10 HPF</td>
###xml 365 366 365 366 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2</td>
###xml 354 366 354 366 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>5&#8211;10/10 HPF</td><td char="." align="char">2</td></tr>
###xml 366 376 366 376 <td xmlns:xlink="http://www.w3.org/1999/xlink">&gt;10/10 HPF</td>
###xml 376 377 376 377 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3</td>
###xml 366 377 366 377 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&gt;10/10 HPF</td><td char="." align="char">3</td></tr>
###xml 377 396 377 396 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="4">Thickness of layers</td>
###xml 396 426 396 426 <td xmlns:xlink="http://www.w3.org/1999/xlink">&lt;7, with intact umbrella cells</td>
###xml 426 427 426 427 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0</td>
###xml 377 427 377 427 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="4">Thickness of layers</td><td>&lt;7, with intact umbrella cells</td><td char="." align="char">0</td></tr>
###xml 427 461 427 461 <td xmlns:xlink="http://www.w3.org/1999/xlink">&lt;7, with the loss of umbrella cell</td>
###xml 461 462 461 462 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1</td>
###xml 427 462 427 462 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&lt;7, with the loss of umbrella cell</td><td char="." align="char">1</td></tr>
###xml 462 492 462 492 <td xmlns:xlink="http://www.w3.org/1999/xlink">&gt;7, with intact umbrella cells</td>
###xml 492 493 492 493 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2</td>
###xml 462 493 462 493 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&gt;7, with intact umbrella cells</td><td char="." align="char">2</td></tr>
###xml 493 527 493 527 <td xmlns:xlink="http://www.w3.org/1999/xlink">&gt;7, with the loss of umbrella cell</td>
###xml 527 528 527 528 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3</td>
###xml 493 528 493 528 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&gt;7, with the loss of umbrella cell</td><td char="." align="char">3</td></tr>
###xml 528 544 528 544 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="3">Cytologic atypia</td>
###xml 544 548 544 548 <td xmlns:xlink="http://www.w3.org/1999/xlink">None</td>
###xml 548 549 548 549 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0</td>
###xml 528 549 528 549 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="3">Cytologic atypia</td><td>None</td><td char="." align="char">0</td></tr>
###xml 549 568 549 568 <td xmlns:xlink="http://www.w3.org/1999/xlink">Diffuse mild atypia</td>
###xml 568 569 568 569 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1</td>
###xml 549 569 549 569 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Diffuse mild atypia</td><td char="." align="char">1</td></tr>
###xml 569 599 569 599 <td xmlns:xlink="http://www.w3.org/1999/xlink">Diffuse moderate&#8211;severe atypia</td>
###xml 599 600 599 600 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2</td>
###xml 569 600 569 600 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Diffuse moderate&#8211;severe atypia</td><td char="." align="char">2</td></tr>
###xml 600 615 600 615 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Papillae fusion</td>
###xml 615 617 615 617 <td xmlns:xlink="http://www.w3.org/1999/xlink">No</td>
###xml 617 618 617 618 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0</td>
###xml 600 618 600 618 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="2">Papillae fusion</td><td>No</td><td char="." align="char">0</td></tr>
###xml 618 621 618 621 <td xmlns:xlink="http://www.w3.org/1999/xlink">Yes</td>
###xml 621 622 621 622 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1</td>
###xml 618 622 618 622 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Yes</td><td char="." align="char">1</td></tr>
###xml 326 622 326 622 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td rowspan="4">Mitosis</td><td>No mitosis</td><td char="." align="char">0</td></tr><tr><td>&lt;5/10 HPF</td><td char="." align="char">1</td></tr><tr><td>5&#8211;10/10 HPF</td><td char="." align="char">2</td></tr><tr><td>&gt;10/10 HPF</td><td char="." align="char">3</td></tr><tr><td rowspan="4">Thickness of layers</td><td>&lt;7, with intact umbrella cells</td><td char="." align="char">0</td></tr><tr><td>&lt;7, with the loss of umbrella cell</td><td char="." align="char">1</td></tr><tr><td>&gt;7, with intact umbrella cells</td><td char="." align="char">2</td></tr><tr><td>&gt;7, with the loss of umbrella cell</td><td char="." align="char">3</td></tr><tr><td rowspan="3">Cytologic atypia</td><td>None</td><td char="." align="char">0</td></tr><tr><td>Diffuse mild atypia</td><td char="." align="char">1</td></tr><tr><td>Diffuse moderate&#8211;severe atypia</td><td char="." align="char">2</td></tr><tr><td rowspan="2">Papillae fusion</td><td>No</td><td char="." align="char">0</td></tr><tr><td>Yes</td><td char="." align="char">1</td></tr></tbody>
###xml 304 622 304 622 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th>Variables</th><th>Features</th><th>Score</th></tr></thead><tbody><tr><td rowspan="4">Mitosis</td><td>No mitosis</td><td char="." align="char">0</td></tr><tr><td>&lt;5/10 HPF</td><td char="." align="char">1</td></tr><tr><td>5&#8211;10/10 HPF</td><td char="." align="char">2</td></tr><tr><td>&gt;10/10 HPF</td><td char="." align="char">3</td></tr><tr><td rowspan="4">Thickness of layers</td><td>&lt;7, with intact umbrella cells</td><td char="." align="char">0</td></tr><tr><td>&lt;7, with the loss of umbrella cell</td><td char="." align="char">1</td></tr><tr><td>&gt;7, with intact umbrella cells</td><td char="." align="char">2</td></tr><tr><td>&gt;7, with the loss of umbrella cell</td><td char="." align="char">3</td></tr><tr><td rowspan="3">Cytologic atypia</td><td>None</td><td char="." align="char">0</td></tr><tr><td>Diffuse mild atypia</td><td char="." align="char">1</td></tr><tr><td>Diffuse moderate&#8211;severe atypia</td><td char="." align="char">2</td></tr><tr><td rowspan="2">Papillae fusion</td><td>No</td><td char="." align="char">0</td></tr><tr><td>Yes</td><td char="." align="char">1</td></tr></tbody></table>
###xml 240 622 240 622 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="21">Diagnostic scoring system for papillary urothelial tumors</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Variables</th><th>Features</th><th>Score</th></tr></thead><tbody><tr><td rowspan="4">Mitosis</td><td>No mitosis</td><td char="." align="char">0</td></tr><tr><td>&lt;5/10 HPF</td><td char="." align="char">1</td></tr><tr><td>5&#8211;10/10 HPF</td><td char="." align="char">2</td></tr><tr><td>&gt;10/10 HPF</td><td char="." align="char">3</td></tr><tr><td rowspan="4">Thickness of layers</td><td>&lt;7, with intact umbrella cells</td><td char="." align="char">0</td></tr><tr><td>&lt;7, with the loss of umbrella cell</td><td char="." align="char">1</td></tr><tr><td>&gt;7, with intact umbrella cells</td><td char="." align="char">2</td></tr><tr><td>&gt;7, with the loss of umbrella cell</td><td char="." align="char">3</td></tr><tr><td rowspan="3">Cytologic atypia</td><td>None</td><td char="." align="char">0</td></tr><tr><td>Diffuse mild atypia</td><td char="." align="char">1</td></tr><tr><td>Diffuse moderate&#8211;severe atypia</td><td char="." align="char">2</td></tr><tr><td rowspan="2">Papillae fusion</td><td>No</td><td char="." align="char">0</td></tr><tr><td>Yes</td><td char="." align="char">1</td></tr></tbody></table></table-wrap>
The entire scoring system is summarized in Table 1. Seemingly clear, a diagnostic conundrum occasionally occurs when a sample falls in the boundary zone. In such cases, diagnostic ancillary studies can be adopted for further clarification. Table 1Diagnostic scoring system for papillary urothelial tumorsVariablesFeaturesScoreMitosisNo mitosis0<5/10 HPF15-10/10 HPF2>10/10 HPF3Thickness of layers<7, with intact umbrella cells0<7, with the loss of umbrella cell1>7, with intact umbrella cells2>7, with the loss of umbrella cell3Cytologic atypiaNone0Diffuse mild atypia1Diffuse moderate-severe atypia2Papillae fusionNo0Yes1
###end p 20
###begin p 21
Diagnostic scoring system for papillary urothelial tumors
###end p 21
###begin title 22
Immunohistochemical analysis
###end title 22
###begin p 23
Three consecutive serial sections from each case were immunostained for MIB, p53, and CK20. In brief, the 4-mum-thick sections of paraffin-embedded tissue were deparaffinized and rehydrated. After a treatment with a 3% hydrogen peroxide solution for 10 min to block endogenous peroxidases, the sections were boiled in 10 mmol/L citrate buffer (pH 6.0) in a microwave oven for 20 min. The sections were subsequently incubated at 4degreesC overnight with the aforementioned primary antibodies. After a thorough rinsing in phosphate-buffered saline, the sections were treated with the DAKO LSAB (labeled streptavidin-biotin) kit, stained with amino-ethyl carbazole and then counterstained with Mayer's hematoxylin.
###end p 23
###begin title 24
Quantitative method
###end title 24
###begin p 25
The immunohistochemical staining results were assessed by a quantitative immunoreactivity score [(ratio of stained urothelial cells per the total number of tumor cells) x 100]. The MIB index was interpreted by counting the number of MIB-positive cells out of a total of 1,000 epithelial cells in the most staining area under the high power magnification (x400). The p53 index was scored by the ratio derived from the number of p53-positive cells out of a total of 1,000 epithelial cells. This ratio was then semi-quantitatively reassorted as 0, 1 (<15%), and 2 (>15%). CK20 focally stained the surface cells in normal urothelium. Whereas this focal and patch staining pattern restrictive to the surface (periphery) was considered negative in our study, we defined CK20 staining as positive only when CK20 antibodies diffusely stained through the entire epithelium. Cells with nuclear MIB and p53 staining as well as cytoplasmic and membranous CK20 staining were regarded as positive cells. The immunohistochemical staining results were analyzed by two independent investigators.
###end p 25
###begin title 26
Recurrence and progression in long-term follow-up
###end title 26
###begin p 27
Individual follow-up times were calculated as the number of months from the date of the diagnostic surgical procedure, which was usually a transurethral resection of the bladder, to the date of the most recent cystoscopy. The length of the follow-up for the whole series ranged from 15 to 195 months (median, 127 months). A recurrence was defined as a tumor which was fulgurated (no histopathological material) or resected (confirmed to be malignant by histological examination). Stage progression was defined as a recurrence with a lamina propria invasion (pT1) or the development of metastatic disease.
###end p 27
###begin title 28
Statistical analysis
###end title 28
###begin p 29
###xml 84 85 84 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 356 357 356 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Statistical analysis was carried out using SPSS (Windows version 10.0). A Student's t test was used to evaluate the associations among the continuous variables. The correlation between immunoreactive variables was analyzed using the Pearson correlation study, and frequency distributions were generated using descriptive statistics (analysis of variance). p < 0.05 was considered to be statistically significant. Associations between histological categories and immunoreactivities as well as with tumor recurrence or progression were assessed by a Chi test. The inter-observer agreement (kappa) was measured for each diagnostic category as well as for each score component. The kappa value was interpreted as follows: 0-0.2, slight; 0.21-0.4, fair; 0.41-0.6, moderate; 0.61-0.8, substantial; and 0.81-1.0, almost perfect.
###end p 29
###begin title 30
Results
###end title 30
###begin p 31
###xml 442 454 <span type="species:ncbi:9606">participants</span>
In the first round, seven pathologists unanimously agreed on the overall diagnosis in 97 of the 175 subjects (55.4%). The lowest consensus rate between the pathologists was in classifying the PUNLMP (27.3%), and the highest consensus rate was in classifying the HGPUC (92.85%). The overall inter-observer agreement in the first round was moderate (kappa = 0.587). After the completion of the first round, all cases were reviewed by all study participants, and a consensus diagnosis was reached. This consensus diagnosis was used as the introduction for a newly designed scoring system combined with ancillary tools mainly based on the MIB index and clinical factors.
###end p 31
###begin p 32
###xml 39 40 39 40 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 45 46 45 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 978 979 978 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 1062 1063 1062 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 1354 1360 1354 1360 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;3</label>
###xml 1407 1408 1407 1408 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1510 1511 1510 1511 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1541 1542 1541 1542 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1600 1601 1600 1601 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1360 1694 1360 1694 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="33">Visualization of PUNLMP with light microscopy. <bold>a</bold> Long- and slender-branched papillae is a characteristic histological clue for a diagnosis of PUNLMP. <bold>b</bold> Branched papillae are fused. <bold>c</bold> Basal palisading feature is another indicator of PUNLMP. <bold>d</bold> Branched fused papillae with basal palisading feature are a characteristic feature of PUNLMP</p>
###xml 1360 1694 1360 1694 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="33">Visualization of PUNLMP with light microscopy. <bold>a</bold> Long- and slender-branched papillae is a characteristic histological clue for a diagnosis of PUNLMP. <bold>b</bold> Branched papillae are fused. <bold>c</bold> Basal palisading feature is another indicator of PUNLMP. <bold>d</bold> Branched fused papillae with basal palisading feature are a characteristic feature of PUNLMP</p></caption>
###xml 1694 1694 1694 1694 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="428_2008_585_Fig3_HTML" id="MO3"/>
###xml 1354 1694 1354 1694 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig.&#160;3</label><caption><p textid="33">Visualization of PUNLMP with light microscopy. <bold>a</bold> Long- and slender-branched papillae is a characteristic histological clue for a diagnosis of PUNLMP. <bold>b</bold> Branched papillae are fused. <bold>c</bold> Basal palisading feature is another indicator of PUNLMP. <bold>d</bold> Branched fused papillae with basal palisading feature are a characteristic feature of PUNLMP</p></caption><graphic position="anchor" xlink:href="428_2008_585_Fig3_HTML" id="MO3"/></fig>
###xml 1694 1701 1694 1701 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 1701 1750 1701 1750 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="34">Total score ranges in papillary urothelial tumors</p>
###xml 1701 1750 1701 1750 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="34">Total score ranges in papillary urothelial tumors</p></caption>
###xml 1750 1752 1750 1752 <th xmlns:xlink="http://www.w3.org/1999/xlink">Dx</th>
###xml 1752 1759 1752 1759 <th xmlns:xlink="http://www.w3.org/1999/xlink">Mitosis</th>
###xml 1759 1778 1759 1778 <th xmlns:xlink="http://www.w3.org/1999/xlink">Thickness of layers</th>
###xml 1778 1784 1778 1784 <th xmlns:xlink="http://www.w3.org/1999/xlink">Atypia</th>
###xml 1784 1797 1784 1797 <th xmlns:xlink="http://www.w3.org/1999/xlink">Fused papilla</th>
###xml 1797 1808 1797 1808 <th xmlns:xlink="http://www.w3.org/1999/xlink">Total score</th>
###xml 1750 1808 1750 1808 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>Dx</th><th>Mitosis</th><th>Thickness of layers</th><th>Atypia</th><th>Fused papilla</th><th>Total score</th></tr>
###xml 1750 1808 1750 1808 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th>Dx</th><th>Mitosis</th><th>Thickness of layers</th><th>Atypia</th><th>Fused papilla</th><th>Total score</th></tr></thead>
###xml 1808 1810 1808 1810 <td xmlns:xlink="http://www.w3.org/1999/xlink">UP</td>
###xml 1810 1813 1810 1813 <td xmlns:xlink="http://www.w3.org/1999/xlink">0&#8211;1</td>
###xml 1813 1814 1813 1814 <td xmlns:xlink="http://www.w3.org/1999/xlink">0</td>
###xml 1814 1815 1814 1815 <td xmlns:xlink="http://www.w3.org/1999/xlink">0</td>
###xml 1815 1816 1815 1816 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0</td>
###xml 1816 1819 1816 1819 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#x2013;" align="char">0&#8211;1</td>
###xml 1808 1819 1808 1819 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>UP</td><td>0&#8211;1</td><td>0</td><td>0</td><td char="." align="char">0</td><td char="&#8211;" align="char">0&#8211;1</td></tr>
###xml 1819 1821 1819 1821 <td xmlns:xlink="http://www.w3.org/1999/xlink">IP</td>
###xml 1821 1824 1821 1824 <td xmlns:xlink="http://www.w3.org/1999/xlink">0&#8211;1</td>
###xml 1824 1827 1824 1827 <td xmlns:xlink="http://www.w3.org/1999/xlink">0&#8211;1</td>
###xml 1827 1830 1827 1830 <td xmlns:xlink="http://www.w3.org/1999/xlink">0&#8211;1</td>
###xml 1830 1831 1830 1831 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1</td>
###xml 1831 1834 1831 1834 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#x2013;" align="char">1&#8211;3</td>
###xml 1819 1834 1819 1834 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>IP</td><td>0&#8211;1</td><td>0&#8211;1</td><td>0&#8211;1</td><td char="." align="char">1</td><td char="&#8211;" align="char">1&#8211;3</td></tr>
###xml 1834 1840 1834 1840 <td xmlns:xlink="http://www.w3.org/1999/xlink">PUNLMP</td>
###xml 1840 1843 1840 1843 <td xmlns:xlink="http://www.w3.org/1999/xlink">0&#8211;1</td>
###xml 1843 1846 1843 1846 <td xmlns:xlink="http://www.w3.org/1999/xlink">1&#8211;2</td>
###xml 1846 1847 1846 1847 <td xmlns:xlink="http://www.w3.org/1999/xlink">0</td>
###xml 1847 1848 1847 1848 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1</td>
###xml 1848 1851 1848 1851 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#x2013;" align="char">2&#8211;4</td>
###xml 1834 1851 1834 1851 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>PUNLMP</td><td>0&#8211;1</td><td>1&#8211;2</td><td>0</td><td char="." align="char">1</td><td char="&#8211;" align="char">2&#8211;4</td></tr>
###xml 1851 1856 1851 1856 <td xmlns:xlink="http://www.w3.org/1999/xlink">LGPUC</td>
###xml 1856 1857 1856 1857 <td xmlns:xlink="http://www.w3.org/1999/xlink">2</td>
###xml 1857 1860 1857 1860 <td xmlns:xlink="http://www.w3.org/1999/xlink">1&#8211;3</td>
###xml 1860 1861 1860 1861 <td xmlns:xlink="http://www.w3.org/1999/xlink">1</td>
###xml 1861 1862 1861 1862 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1</td>
###xml 1862 1865 1862 1865 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#x2013;" align="char">5&#8211;7</td>
###xml 1851 1865 1851 1865 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>LGPUC</td><td>2</td><td>1&#8211;3</td><td>1</td><td char="." align="char">1</td><td char="&#8211;" align="char">5&#8211;7</td></tr>
###xml 1865 1870 1865 1870 <td xmlns:xlink="http://www.w3.org/1999/xlink">HGPUC</td>
###xml 1870 1871 1870 1871 <td xmlns:xlink="http://www.w3.org/1999/xlink">3</td>
###xml 1871 1874 1871 1874 <td xmlns:xlink="http://www.w3.org/1999/xlink">2&#8211;3</td>
###xml 1874 1875 1874 1875 <td xmlns:xlink="http://www.w3.org/1999/xlink">2</td>
###xml 1875 1876 1875 1876 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1</td>
###xml 1876 1879 1876 1879 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#x2013;" align="char">8&#8211;9</td>
###xml 1865 1879 1865 1879 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>HGPUC</td><td>3</td><td>2&#8211;3</td><td>2</td><td char="." align="char">1</td><td char="&#8211;" align="char">8&#8211;9</td></tr>
###xml 1808 1879 1808 1879 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td>UP</td><td>0&#8211;1</td><td>0</td><td>0</td><td char="." align="char">0</td><td char="&#8211;" align="char">0&#8211;1</td></tr><tr><td>IP</td><td>0&#8211;1</td><td>0&#8211;1</td><td>0&#8211;1</td><td char="." align="char">1</td><td char="&#8211;" align="char">1&#8211;3</td></tr><tr><td>PUNLMP</td><td>0&#8211;1</td><td>1&#8211;2</td><td>0</td><td char="." align="char">1</td><td char="&#8211;" align="char">2&#8211;4</td></tr><tr><td>LGPUC</td><td>2</td><td>1&#8211;3</td><td>1</td><td char="." align="char">1</td><td char="&#8211;" align="char">5&#8211;7</td></tr><tr><td>HGPUC</td><td>3</td><td>2&#8211;3</td><td>2</td><td char="." align="char">1</td><td char="&#8211;" align="char">8&#8211;9</td></tr></tbody>
###xml 1750 1879 1750 1879 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th>Dx</th><th>Mitosis</th><th>Thickness of layers</th><th>Atypia</th><th>Fused papilla</th><th>Total score</th></tr></thead><tbody><tr><td>UP</td><td>0&#8211;1</td><td>0</td><td>0</td><td char="." align="char">0</td><td char="&#8211;" align="char">0&#8211;1</td></tr><tr><td>IP</td><td>0&#8211;1</td><td>0&#8211;1</td><td>0&#8211;1</td><td char="." align="char">1</td><td char="&#8211;" align="char">1&#8211;3</td></tr><tr><td>PUNLMP</td><td>0&#8211;1</td><td>1&#8211;2</td><td>0</td><td char="." align="char">1</td><td char="&#8211;" align="char">2&#8211;4</td></tr><tr><td>LGPUC</td><td>2</td><td>1&#8211;3</td><td>1</td><td char="." align="char">1</td><td char="&#8211;" align="char">5&#8211;7</td></tr><tr><td>HGPUC</td><td>3</td><td>2&#8211;3</td><td>2</td><td char="." align="char">1</td><td char="&#8211;" align="char">8&#8211;9</td></tr></tbody></table>
###xml 1879 1958 1879 1958 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="35">Atypia means hyperchromacia, irregular nuclear contours and prominent nucleoli.</p>
###xml 1958 1960 1958 1960 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UP</italic>
###xml 1983 1985 1983 1985 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IP</italic>
###xml 2006 2012 2006 2012 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PUNLMP</italic>
###xml 2068 2073 2068 2073 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LGPUC</italic>
###xml 2116 2121 2116 2121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HGPUC</italic>
###xml 1958 2163 1958 2163 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="36"><italic>UP</italic> Urothelial papilloma, <italic>IP</italic> inverted papilloma, <italic>PUNLMP</italic> papillary urothelial neoplasm low malignant potential, <italic>LGPUC</italic> low-grade papillary urothelial carcinoma, <italic>HGPUC</italic> high-grade papillary urothelial carcinoma</p>
###xml 1879 2163 1879 2163 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="35">Atypia means hyperchromacia, irregular nuclear contours and prominent nucleoli.</p><p textid="36"><italic>UP</italic> Urothelial papilloma, <italic>IP</italic> inverted papilloma, <italic>PUNLMP</italic> papillary urothelial neoplasm low malignant potential, <italic>LGPUC</italic> low-grade papillary urothelial carcinoma, <italic>HGPUC</italic> high-grade papillary urothelial carcinoma</p></table-wrap-foot>
###xml 1694 2163 1694 2163 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="34">Total score ranges in papillary urothelial tumors</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Dx</th><th>Mitosis</th><th>Thickness of layers</th><th>Atypia</th><th>Fused papilla</th><th>Total score</th></tr></thead><tbody><tr><td>UP</td><td>0&#8211;1</td><td>0</td><td>0</td><td char="." align="char">0</td><td char="&#8211;" align="char">0&#8211;1</td></tr><tr><td>IP</td><td>0&#8211;1</td><td>0&#8211;1</td><td>0&#8211;1</td><td char="." align="char">1</td><td char="&#8211;" align="char">1&#8211;3</td></tr><tr><td>PUNLMP</td><td>0&#8211;1</td><td>1&#8211;2</td><td>0</td><td char="." align="char">1</td><td char="&#8211;" align="char">2&#8211;4</td></tr><tr><td>LGPUC</td><td>2</td><td>1&#8211;3</td><td>1</td><td char="." align="char">1</td><td char="&#8211;" align="char">5&#8211;7</td></tr><tr><td>HGPUC</td><td>3</td><td>2&#8211;3</td><td>2</td><td char="." align="char">1</td><td char="&#8211;" align="char">8&#8211;9</td></tr></tbody></table><table-wrap-foot><p textid="35">Atypia means hyperchromacia, irregular nuclear contours and prominent nucleoli.</p><p textid="36"><italic>UP</italic> Urothelial papilloma, <italic>IP</italic> inverted papilloma, <italic>PUNLMP</italic> papillary urothelial neoplasm low malignant potential, <italic>LGPUC</italic> low-grade papillary urothelial carcinoma, <italic>HGPUC</italic> high-grade papillary urothelial carcinoma</p></table-wrap-foot></table-wrap>
The scoring system, as shown in Tables 1 and 2, consists of six separately graded components, the scores for which were then added to determine the total score equivalent to a diagnostic category. This scoring system was significantly improved with the adoption of the new scoring scheme in the second round (kappa = 0.832). The inter-observer agreement on separate components of this scoring system showed a substantially increased the classification to a perfect level of agreement: a kappa of 0.754 for mitosis (substantial agreement), a kappa of 0.635 for cellular thickness (substantial), and a kappa of 0.556 for cellular atypia (moderate agreement). With specific regards to PUNLMP, the result of which had the least consensus, the inter-observer agreement was substantially improved (kappa = 0.670). The most consistent findings in low magnification of PUNLMP were long and slender papillae with partly fused and branched papillae, and no obvious cytologic atypia (Fig. 3). Basal palisading features in each papilla can be accounted for the PUNLMP (Fig. 3c,d). It should be pointed that thickness more than seven layers with loss of surface cells in any papillae should never be seen in PUNLMP. The best diagnostic reproducibility for PUNLMP was mitosis. Randomly scattered mitosis was the most important finding against the diagnosis of PUNLMP. Fig. 3Visualization of PUNLMP with light microscopy. a Long- and slender-branched papillae is a characteristic histological clue for a diagnosis of PUNLMP. b Branched papillae are fused. c Basal palisading feature is another indicator of PUNLMP. d Branched fused papillae with basal palisading feature are a characteristic feature of PUNLMPTable 2Total score ranges in papillary urothelial tumorsDxMitosisThickness of layersAtypiaFused papillaTotal scoreUP0-10000-1IP0-10-10-111-3PUNLMP0-11-2012-4LGPUC21-3115-7HGPUC32-3218-9Atypia means hyperchromacia, irregular nuclear contours and prominent nucleoli.UP Urothelial papilloma, IP inverted papilloma, PUNLMP papillary urothelial neoplasm low malignant potential, LGPUC low-grade papillary urothelial carcinoma, HGPUC high-grade papillary urothelial carcinoma
###end p 32
###begin p 33
###xml 47 48 47 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 150 151 150 151 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 181 182 181 182 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 240 241 240 241 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
Visualization of PUNLMP with light microscopy. a Long- and slender-branched papillae is a characteristic histological clue for a diagnosis of PUNLMP. b Branched papillae are fused. c Basal palisading feature is another indicator of PUNLMP. d Branched fused papillae with basal palisading feature are a characteristic feature of PUNLMP
###end p 33
###begin p 34
Total score ranges in papillary urothelial tumors
###end p 34
###begin p 35
Atypia means hyperchromacia, irregular nuclear contours and prominent nucleoli.
###end p 35
###begin p 36
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UP</italic>
###xml 25 27 25 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IP</italic>
###xml 48 54 48 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PUNLMP</italic>
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LGPUC</italic>
###xml 158 163 158 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HGPUC</italic>
UP Urothelial papilloma, IP inverted papilloma, PUNLMP papillary urothelial neoplasm low malignant potential, LGPUC low-grade papillary urothelial carcinoma, HGPUC high-grade papillary urothelial carcinoma
###end p 36
###begin title 37
Clinicopathological classification of PUN
###end title 37
###begin p 38
###xml 9 16 <span type="species:ncbi:9606">patient</span>
###xml 364 371 <span type="species:ncbi:9606">patient</span>
###xml 949 957 <span type="species:ncbi:9606">patients</span>
###xml 1167 1175 <span type="species:ncbi:9606">patients</span>
The mean patient age at the first diagnosis of UP, PUNLMP, PULC, and PUHC was 62.6, 68.4, 67.1, and 69.3 years, respectively. The following clinical parameters were included: single vs. multiple, small (less than 1-2 cm) vs. large (more than 2 cm), no recurrence vs. recurrence, and no progression vs. progression. UP was all single and small, but recurred in one patient (14.3%). No progression or association with LGPUC was found in any of the UP cases. IP was predominantly single, but 27.3% (6/22) of the cases were multiple, and 13.6% (3/22) of the cases were associated with LGPUC. Three cases of IP associated with LGPUC were typically benign, which were easily differentiated from inverted urothelial carcinoma. None of the IP cases progressed to LGPUC. PUNLMP frequently presents with a single and small lesion. Of the PUNLMP cases, 13.6% (3/22) had two or more lesions, but all of them were small, which were less than 1 cm. Of the PUNLMP patients, 18.2% (4/22) had a late recurrence (average 21.5 months) and 9.1% (2/22) progressed to LGPUC (after 5 and 56 months, respectively), but never underwent stage progression to invade muscle proper. Of the LGPUC patients, 70.4% (38/54) demonstrated a significantly higher recurrence frequency and 9.3% (5/54) progressed to higher stages.
###end p 38
###begin title 39
MIB, p53 indices, and cytokeratin 20 expression according to papillary urothelial tumors
###end title 39
###begin p 40
###xml 112 113 112 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab3" ref-type="table">3</xref>
###xml 213 214 213 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 299 300 299 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 447 448 447 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 552 553 552 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 896 897 896 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 990 996 990 996 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;4</label>
###xml 1016 1017 1016 1017 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1056 1069 1056 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink">closed circle</italic>
###xml 1103 1113 1103 1113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">semicircle</italic>
###xml 1116 1117 1116 1117 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1212 1213 1212 1213 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 996 1267 996 1267 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="41">MIB index of LGPUC. <bold>a</bold> Areas of thick trabeculated papillae (<italic>closed circle</italic>) are opposed to areas of PUNLMP (<italic>semicircle</italic>). <bold>b</bold> Notice many scattered MIB indexes in the portion of thick trabeculae, which represents LGPUC. <bold>c</bold> Little MIB indexes were recognized in areas of PUNLMP</p>
###xml 996 1267 996 1267 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="41">MIB index of LGPUC. <bold>a</bold> Areas of thick trabeculated papillae (<italic>closed circle</italic>) are opposed to areas of PUNLMP (<italic>semicircle</italic>). <bold>b</bold> Notice many scattered MIB indexes in the portion of thick trabeculae, which represents LGPUC. <bold>c</bold> Little MIB indexes were recognized in areas of PUNLMP</p></caption>
###xml 1267 1267 1267 1267 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="428_2008_585_Fig4_HTML" id="MO4"/>
###xml 990 1267 990 1267 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig4"><label>Fig.&#160;4</label><caption><p textid="41">MIB index of LGPUC. <bold>a</bold> Areas of thick trabeculated papillae (<italic>closed circle</italic>) are opposed to areas of PUNLMP (<italic>semicircle</italic>). <bold>b</bold> Notice many scattered MIB indexes in the portion of thick trabeculae, which represents LGPUC. <bold>c</bold> Little MIB indexes were recognized in areas of PUNLMP</p></caption><graphic position="anchor" xlink:href="428_2008_585_Fig4_HTML" id="MO4"/></fig>
###xml 1267 1273 1267 1273 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;5</label>
###xml 1325 1326 1325 1326 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1374 1375 1374 1375 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1426 1427 1426 1427 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1478 1479 1478 1479 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1273 1516 1273 1516 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="42">Cytokeratin 20 expression pattern analysis in PUNs. <bold>a</bold> CK20 expression was restricted to the surface. <bold>b</bold> Patchy areas of CK20 immunoreactivity had spread. <bold>c</bold> Solid compactum of positive expression was noted. <bold>d</bold> Diffuse CK20 expression was observed</p>
###xml 1273 1516 1273 1516 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="42">Cytokeratin 20 expression pattern analysis in PUNs. <bold>a</bold> CK20 expression was restricted to the surface. <bold>b</bold> Patchy areas of CK20 immunoreactivity had spread. <bold>c</bold> Solid compactum of positive expression was noted. <bold>d</bold> Diffuse CK20 expression was observed</p></caption>
###xml 1516 1516 1516 1516 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="428_2008_585_Fig5_HTML" id="MO5"/>
###xml 1267 1516 1267 1516 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig5"><label>Fig.&#160;5</label><caption><p textid="42">Cytokeratin 20 expression pattern analysis in PUNs. <bold>a</bold> CK20 expression was restricted to the surface. <bold>b</bold> Patchy areas of CK20 immunoreactivity had spread. <bold>c</bold> Solid compactum of positive expression was noted. <bold>d</bold> Diffuse CK20 expression was observed</p></caption><graphic position="anchor" xlink:href="428_2008_585_Fig5_HTML" id="MO5"/></fig>
###xml 1516 1523 1516 1523 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;3</label>
###xml 1523 1581 1523 1581 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="43">Immunohistochemical results in papillary urothelial tumors</p>
###xml 1523 1581 1523 1581 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="43">Immunohistochemical results in papillary urothelial tumors</p></caption>
###xml 1581 1582 1581 1582 <th xmlns:xlink="http://www.w3.org/1999/xlink">&#160;</th>
###xml 1582 1595 1582 1595 <th xmlns:xlink="http://www.w3.org/1999/xlink">Summing score</th>
###xml 1595 1628 1595 1628 <th xmlns:xlink="http://www.w3.org/1999/xlink">MIB (avg. Nc. index) cut-off &gt;15%</th>
###xml 1628 1667 1628 1667 <th xmlns:xlink="http://www.w3.org/1999/xlink">p53 (no. of strong index, cut-off &gt;15%)</th>
###xml 1667 1690 1667 1690 <th xmlns:xlink="http://www.w3.org/1999/xlink">CK20 (intense /diffuse)</th>
###xml 1581 1690 1581 1690 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>&#160;</th><th>Summing score</th><th>MIB (avg. Nc. index) cut-off &gt;15%</th><th>p53 (no. of strong index, cut-off &gt;15%)</th><th>CK20 (intense /diffuse)</th></tr>
###xml 1581 1690 1581 1690 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th>&#160;</th><th>Summing score</th><th>MIB (avg. Nc. index) cut-off &gt;15%</th><th>p53 (no. of strong index, cut-off &gt;15%)</th><th>CK20 (intense /diffuse)</th></tr></thead>
###xml 1694 1695 1694 1695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1690 1700 1690 1700 <td xmlns:xlink="http://www.w3.org/1999/xlink">UP (<italic>n</italic>&#8201;=&#8201;7)</td>
###xml 1700 1713 1700 1711 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">0.42&#8201;&#177;&#8201;0.01</td>
###xml 1713 1726 1711 1722 <td xmlns:xlink="http://www.w3.org/1999/xlink">5.85&#8201;&#177;&#8201;0.12</td>
###xml 1726 1727 1722 1723 <td xmlns:xlink="http://www.w3.org/1999/xlink">0</td>
###xml 1727 1736 1723 1732 <td xmlns:xlink="http://www.w3.org/1999/xlink">2 (28.6%)</td>
###xml 1690 1736 1690 1732 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>UP (<italic>n</italic>&#8201;=&#8201;7)</td><td char="&#177;" align="char">0.42&#8201;&#177;&#8201;0.01</td><td>5.85&#8201;&#177;&#8201;0.12</td><td>0</td><td>2 (28.6%)</td></tr>
###xml 1740 1741 1736 1737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1736 1747 1732 1743 <td xmlns:xlink="http://www.w3.org/1999/xlink">IP (<italic>n</italic>&#8201;=&#8201;22)</td>
###xml 1747 1760 1743 1754 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">1.63&#8201;&#177;&#8201;2.54</td>
###xml 1760 1773 1754 1765 <td xmlns:xlink="http://www.w3.org/1999/xlink">7.63&#8201;&#177;&#8201;3.57</td>
###xml 1773 1782 1765 1774 <td xmlns:xlink="http://www.w3.org/1999/xlink">5 (22.7%)</td>
###xml 1785 1786 1777 1778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1782 1795 1774 1787 <td xmlns:xlink="http://www.w3.org/1999/xlink">7 (<italic>n</italic>&#8201;=&#8201;31.8%)</td>
###xml 1736 1795 1732 1787 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>IP (<italic>n</italic>&#8201;=&#8201;22)</td><td char="&#177;" align="char">1.63&#8201;&#177;&#8201;2.54</td><td>7.63&#8201;&#177;&#8201;3.57</td><td>5 (22.7%)</td><td>7 (<italic>n</italic>&#8201;=&#8201;31.8%)</td></tr>
###xml 1803 1804 1795 1796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1795 1810 1787 1802 <td xmlns:xlink="http://www.w3.org/1999/xlink">PUNLMP (<italic>n</italic>&#8201;=&#8201;22)</td>
###xml 1810 1823 1802 1813 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">3.08&#8201;&#177;&#8201;1.91</td>
###xml 1823 1836 1813 1824 <td xmlns:xlink="http://www.w3.org/1999/xlink">8.29&#8201;&#177;&#8201;2.14</td>
###xml 1836 1845 1824 1833 <td xmlns:xlink="http://www.w3.org/1999/xlink">7 (31.8%)</td>
###xml 1849 1850 1837 1838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1845 1859 1833 1847 <td xmlns:xlink="http://www.w3.org/1999/xlink">10 (<italic>n</italic>&#8201;=&#8201;45.5%)</td>
###xml 1795 1859 1787 1847 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>PUNLMP (<italic>n</italic>&#8201;=&#8201;22)</td><td char="&#177;" align="char">3.08&#8201;&#177;&#8201;1.91</td><td>8.29&#8201;&#177;&#8201;2.14</td><td>7 (31.8%)</td><td>10 (<italic>n</italic>&#8201;=&#8201;45.5%)</td></tr>
###xml 1866 1867 1854 1855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1859 1873 1847 1861 <td xmlns:xlink="http://www.w3.org/1999/xlink">LGPUC (<italic>n</italic>&#8201;=&#8201;54)</td>
###xml 1873 1886 1861 1872 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">6.28&#8201;&#177;&#8201;1.04</td>
###xml 1886 1901 1872 1885 <td xmlns:xlink="http://www.w3.org/1999/xlink">38.74&#8201;&#177;&#8201;12.25</td>
###xml 1901 1911 1885 1895 <td xmlns:xlink="http://www.w3.org/1999/xlink">25 (46.3%)</td>
###xml 1915 1916 1899 1900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1911 1925 1895 1909 <td xmlns:xlink="http://www.w3.org/1999/xlink">18 (<italic>n</italic>&#8201;=&#8201;33.3%)</td>
###xml 1859 1925 1847 1909 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>LGPUC (<italic>n</italic>&#8201;=&#8201;54)</td><td char="&#177;" align="char">6.28&#8201;&#177;&#8201;1.04</td><td>38.74&#8201;&#177;&#8201;12.25</td><td>25 (46.3%)</td><td>18 (<italic>n</italic>&#8201;=&#8201;33.3%)</td></tr>
###xml 1932 1933 1916 1917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1925 1939 1909 1923 <td xmlns:xlink="http://www.w3.org/1999/xlink">HGPUC (<italic>n</italic>&#8201;=&#8201;70)</td>
###xml 1939 1950 1923 1932 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">8.5&#8201;&#177;&#8201;0.5</td>
###xml 1950 1964 1932 1944 <td xmlns:xlink="http://www.w3.org/1999/xlink">58.32&#8201;&#177;&#8201;3.69</td>
###xml 1964 1974 1944 1954 <td xmlns:xlink="http://www.w3.org/1999/xlink">48 (68.6%)</td>
###xml 1978 1979 1958 1959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1974 1988 1954 1968 <td xmlns:xlink="http://www.w3.org/1999/xlink">25 (<italic>n</italic>&#8201;=&#8201;35.7%)</td>
###xml 1925 1988 1909 1968 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>HGPUC (<italic>n</italic>&#8201;=&#8201;70)</td><td char="&#177;" align="char">8.5&#8201;&#177;&#8201;0.5</td><td>58.32&#8201;&#177;&#8201;3.69</td><td>48 (68.6%)</td><td>25 (<italic>n</italic>&#8201;=&#8201;35.7%)</td></tr>
###xml 1690 1988 1690 1968 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td>UP (<italic>n</italic>&#8201;=&#8201;7)</td><td char="&#177;" align="char">0.42&#8201;&#177;&#8201;0.01</td><td>5.85&#8201;&#177;&#8201;0.12</td><td>0</td><td>2 (28.6%)</td></tr><tr><td>IP (<italic>n</italic>&#8201;=&#8201;22)</td><td char="&#177;" align="char">1.63&#8201;&#177;&#8201;2.54</td><td>7.63&#8201;&#177;&#8201;3.57</td><td>5 (22.7%)</td><td>7 (<italic>n</italic>&#8201;=&#8201;31.8%)</td></tr><tr><td>PUNLMP (<italic>n</italic>&#8201;=&#8201;22)</td><td char="&#177;" align="char">3.08&#8201;&#177;&#8201;1.91</td><td>8.29&#8201;&#177;&#8201;2.14</td><td>7 (31.8%)</td><td>10 (<italic>n</italic>&#8201;=&#8201;45.5%)</td></tr><tr><td>LGPUC (<italic>n</italic>&#8201;=&#8201;54)</td><td char="&#177;" align="char">6.28&#8201;&#177;&#8201;1.04</td><td>38.74&#8201;&#177;&#8201;12.25</td><td>25 (46.3%)</td><td>18 (<italic>n</italic>&#8201;=&#8201;33.3%)</td></tr><tr><td>HGPUC (<italic>n</italic>&#8201;=&#8201;70)</td><td char="&#177;" align="char">8.5&#8201;&#177;&#8201;0.5</td><td>58.32&#8201;&#177;&#8201;3.69</td><td>48 (68.6%)</td><td>25 (<italic>n</italic>&#8201;=&#8201;35.7%)</td></tr></tbody>
###xml 1581 1988 1581 1968 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th>&#160;</th><th>Summing score</th><th>MIB (avg. Nc. index) cut-off &gt;15%</th><th>p53 (no. of strong index, cut-off &gt;15%)</th><th>CK20 (intense /diffuse)</th></tr></thead><tbody><tr><td>UP (<italic>n</italic>&#8201;=&#8201;7)</td><td char="&#177;" align="char">0.42&#8201;&#177;&#8201;0.01</td><td>5.85&#8201;&#177;&#8201;0.12</td><td>0</td><td>2 (28.6%)</td></tr><tr><td>IP (<italic>n</italic>&#8201;=&#8201;22)</td><td char="&#177;" align="char">1.63&#8201;&#177;&#8201;2.54</td><td>7.63&#8201;&#177;&#8201;3.57</td><td>5 (22.7%)</td><td>7 (<italic>n</italic>&#8201;=&#8201;31.8%)</td></tr><tr><td>PUNLMP (<italic>n</italic>&#8201;=&#8201;22)</td><td char="&#177;" align="char">3.08&#8201;&#177;&#8201;1.91</td><td>8.29&#8201;&#177;&#8201;2.14</td><td>7 (31.8%)</td><td>10 (<italic>n</italic>&#8201;=&#8201;45.5%)</td></tr><tr><td>LGPUC (<italic>n</italic>&#8201;=&#8201;54)</td><td char="&#177;" align="char">6.28&#8201;&#177;&#8201;1.04</td><td>38.74&#8201;&#177;&#8201;12.25</td><td>25 (46.3%)</td><td>18 (<italic>n</italic>&#8201;=&#8201;33.3%)</td></tr><tr><td>HGPUC (<italic>n</italic>&#8201;=&#8201;70)</td><td char="&#177;" align="char">8.5&#8201;&#177;&#8201;0.5</td><td>58.32&#8201;&#177;&#8201;3.69</td><td>48 (68.6%)</td><td>25 (<italic>n</italic>&#8201;=&#8201;35.7%)</td></tr></tbody></table>
###xml 1988 2002 1968 1982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Avg. Nc. index</italic>
###xml 1988 2024 1968 2004 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="44"><italic>Avg. Nc. index</italic> Average nuclear index</p>
###xml 1988 2024 1968 2004 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="44"><italic>Avg. Nc. index</italic> Average nuclear index</p></table-wrap-foot>
###xml 1516 2024 1516 2004 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab3"><label>Table&#160;3</label><caption><p textid="43">Immunohistochemical results in papillary urothelial tumors</p></caption><table frame="hsides" rules="groups"><thead><tr><th>&#160;</th><th>Summing score</th><th>MIB (avg. Nc. index) cut-off &gt;15%</th><th>p53 (no. of strong index, cut-off &gt;15%)</th><th>CK20 (intense /diffuse)</th></tr></thead><tbody><tr><td>UP (<italic>n</italic>&#8201;=&#8201;7)</td><td char="&#177;" align="char">0.42&#8201;&#177;&#8201;0.01</td><td>5.85&#8201;&#177;&#8201;0.12</td><td>0</td><td>2 (28.6%)</td></tr><tr><td>IP (<italic>n</italic>&#8201;=&#8201;22)</td><td char="&#177;" align="char">1.63&#8201;&#177;&#8201;2.54</td><td>7.63&#8201;&#177;&#8201;3.57</td><td>5 (22.7%)</td><td>7 (<italic>n</italic>&#8201;=&#8201;31.8%)</td></tr><tr><td>PUNLMP (<italic>n</italic>&#8201;=&#8201;22)</td><td char="&#177;" align="char">3.08&#8201;&#177;&#8201;1.91</td><td>8.29&#8201;&#177;&#8201;2.14</td><td>7 (31.8%)</td><td>10 (<italic>n</italic>&#8201;=&#8201;45.5%)</td></tr><tr><td>LGPUC (<italic>n</italic>&#8201;=&#8201;54)</td><td char="&#177;" align="char">6.28&#8201;&#177;&#8201;1.04</td><td>38.74&#8201;&#177;&#8201;12.25</td><td>25 (46.3%)</td><td>18 (<italic>n</italic>&#8201;=&#8201;33.3%)</td></tr><tr><td>HGPUC (<italic>n</italic>&#8201;=&#8201;70)</td><td char="&#177;" align="char">8.5&#8201;&#177;&#8201;0.5</td><td>58.32&#8201;&#177;&#8201;3.69</td><td>48 (68.6%)</td><td>25 (<italic>n</italic>&#8201;=&#8201;35.7%)</td></tr></tbody></table><table-wrap-foot><p textid="44"><italic>Avg. Nc. index</italic> Average nuclear index</p></table-wrap-foot></table-wrap>
Immunohistochemical results of papillary urothelial tumors based on new scoring system were summarized in Table 3. The MIB index was variably expressed and increased proportionately with disease progression (Fig. 4). The mean MIB index was 5.85, 8.29, 38.74, and 58.32 in UP, LMP, LGPUC, and HGPUC (p value < 0.001), respectively. The MIB index was relatively and significantly higher in recurred PUNLMP than in non-recurrent cases (16.5 vs. 8.1, p < 0.001). Atypia in surface cells occasionally seen in papillomas were not immunoreactive to MIB (Fig. 2c,d, and e). p53 had variable expression ranges in urothelial tumors and no significant association with recurrence in spite of an apparent tendency towards disease progression. CK20 was diffusely immunoreactive in all layers of some PUNs, whereas these cells are negative or focally reactive in the superficial cells of UP and IP cases (Fig. 5). However, CK20 staining had no significant association with clinicopathological variables. Fig. 4MIB index of LGPUC. a Areas of thick trabeculated papillae (closed circle) are opposed to areas of PUNLMP (semicircle). b Notice many scattered MIB indexes in the portion of thick trabeculae, which represents LGPUC. c Little MIB indexes were recognized in areas of PUNLMPFig. 5Cytokeratin 20 expression pattern analysis in PUNs. a CK20 expression was restricted to the surface. b Patchy areas of CK20 immunoreactivity had spread. c Solid compactum of positive expression was noted. d Diffuse CK20 expression was observedTable 3Immunohistochemical results in papillary urothelial tumors Summing scoreMIB (avg. Nc. index) cut-off >15%p53 (no. of strong index, cut-off >15%)CK20 (intense /diffuse)UP (n = 7)0.42 +/- 0.015.85 +/- 0.1202 (28.6%)IP (n = 22)1.63 +/- 2.547.63 +/- 3.575 (22.7%)7 (n = 31.8%)PUNLMP (n = 22)3.08 +/- 1.918.29 +/- 2.147 (31.8%)10 (n = 45.5%)LGPUC (n = 54)6.28 +/- 1.0438.74 +/- 12.2525 (46.3%)18 (n = 33.3%)HGPUC (n = 70)8.5 +/- 0.558.32 +/- 3.6948 (68.6%)25 (n = 35.7%)Avg. Nc. index Average nuclear index
###end p 40
###begin p 41
###xml 20 21 20 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 60 73 60 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">closed circle</italic>
###xml 107 117 107 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">semicircle</italic>
###xml 120 121 120 121 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 216 217 216 217 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
MIB index of LGPUC. a Areas of thick trabeculated papillae (closed circle) are opposed to areas of PUNLMP (semicircle). b Notice many scattered MIB indexes in the portion of thick trabeculae, which represents LGPUC. c Little MIB indexes were recognized in areas of PUNLMP
###end p 41
###begin p 42
###xml 52 53 52 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 101 102 101 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 153 154 153 154 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 205 206 205 206 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
Cytokeratin 20 expression pattern analysis in PUNs. a CK20 expression was restricted to the surface. b Patchy areas of CK20 immunoreactivity had spread. c Solid compactum of positive expression was noted. d Diffuse CK20 expression was observed
###end p 42
###begin p 43
Immunohistochemical results in papillary urothelial tumors
###end p 43
###begin p 44
###xml 0 14 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Avg. Nc. index</italic>
Avg. Nc. index Average nuclear index
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 543 544 543 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 559 561 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 660 661 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 775 777 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
PUNs are a common characteristic of the indolent nature of papillary tumors with cytologically banal features. They are often difficult to define with solid classifying criteria for the low-grade, non-invasive PUNs, benign papillomas, papillary urothelial neoplasms of low malignant potential (PUNLMP), and low-grade papillary urothelial carcinomas (LGPUC). The classification of PUNLMP was initially introduced to replace the previously designated WHO grade 1 urothelial carcinoma that was defined by the 1998 WHO/ISUP classification system [7, 23]. Murphy [17] interpreted some of the 1973 WHO grade 1 tumors as PUNLMP and some as LGPUC, Bostwick and Mikuz [3] translated the 1973 WHO grade 1, 2, and 3 tumors as PUNLMP, LGPUC, and HGPUC, respectively. Reuter and Melamed [20] interpreted the 1973 WHO grade 1 tumors as PUNLMP, grade 2 as LGPUC or HGPUC, and grade 3 as HGPUC.
###end p 46
###begin p 47
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 1179 1180 1179 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 1182 1183 1182 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
Based on the histopathological findings, both architectural atypia and cellular atypia are prime parameters that include thickness of papillae, fused papillae, cellular pleomorphism, and mitosis. However, some cases can often have overlapping findings. In a multi-institutional survey in the Korean Urologic Pathology Society, PUNs diagnoses were given little consensus by urologic pathologists, despite the fixed criteria introduced by the WHO guide. Our substantial discrepancies in diagnoses are quite similar to data collected from other institutes [16, 23]. Architectural atypia, such as a thickness more than seven layers and fused papillae, are very useful in differentiating benign from worse lesions, but are sometimes confusing due to tangential sections. In general, cytological atypia is much more reproducible than architectural atypia. Cellular atypia can be recognized only along superficial layers or in a random distribution, whether mild or severe. We found that the former lacks ki67 expression, which may represent degenerative changes, not proliferation. Cytologic atypia that is restricted to the superficial layer can be found in urothelial benign tumors [4, 6]. Mitosis can be the most representative and the highly reproducible variable, when using the total number of mitoses from ten HPF (x400) selected at random. The benign category of PUN demonstrated rare, but regular mitoses near the basal layer of the urothelium. The loss of umbrella cells, degree of the nuclear groove preservation, cytologic spindling or epithelioid feature, and palisading basal layers can be another supportive findings, but excluded in this algorithm, because these findings appear too subjective and less reproducible. For instance, the loss of umbrella cells may be caused by a manipulation or a biopsy procedure. Conversely, well-preserved umbrella cells can be observed in overt carcinoma. Basal palisading features in each papilla can be, however, useful in PUNLMP or IP, whereas overt epithelioid features instead of spindling can be a supportive finding to favor carcinoma over PUNLMP or papilloma.
###end p 47
###begin p 48
For the purpose of achieving a reproducible diagnosis for PUN, a scoring method based on pathological parameters was recently proposed by the Korean Urologic Pathology Society. The main principle behind this scoring system is for each parameter to be scored differently with different weights of implication. For instance, more concordant parameters such as mitosis and with thickness of layers were scored by a three-tiered system. The scoring of atypia was two tiered, and fused papillae was one tiered. Each diagnosis can be clearly divided when using this system. Furthermore, PUNs were well categorized with a high consensus rate upon the application of this algorithm. A useful tool under the routine microscopy would be an algorithm derived from our peer-review data in the form of flow diagram starting features seen at low power (modest thickness with focal fused papillae) progressing to medium power (no obvious atypia) and high power (scanty mitosis) ending up at a diagnosis of PUNLMP.
###end p 48
###begin p 49
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 503 505 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 743 744 743 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 783 785 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
The helpful ancillary findings for this new scoring system were the MIB index and clinical findings of multiplicity, size, and recurrences. Since the MIB index has been widely known as an independent prognostic predictor of recurrence [2, 10, 14], it was introduced to distinguish between PUNs. Most authors reported that the MIB index of recurrent predictors and poor prognostic factors is around 10% of the cut-off level. Using the same method, the MIB index varies according to the time of fixation [22]. The MIB index in specimens fixed for 50 h (over the weekend) was significantly lower than the overnight-fixed specimens. High p53 and MIB expression could be significant prognostic factors in the univariate analysis of bladder cancer [8], while p53 is an independent factor [21].
###end p 49
###begin p 50
###xml 332 333 332 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 391 392 391 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 503 504 503 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
CK20 showed diffuse immunoreactivity in all layers of certain PUNs, while negative or focally reactive in the superficial cells of UP and IP cases. The diffuse and strong expression of CK20 was correlated to the tumor severity. Although highly controversial with regard to their implication of CK20 expression loss, Harnden et al. [9] found a decreased CK20 expression to be an independent (p < 0.0001) predictor of tumor recurrence in papillary tumors. Unlike the findings reported by Alsheikh et al. [1], our data did not reveal a significant correlation with tumor recurrence.
###end p 50
###begin p 51
###xml 81 89 <span type="species:ncbi:9606">patients</span>
###xml 336 344 <span type="species:ncbi:9606">patients</span>
###xml 497 505 <span type="species:ncbi:9606">patients</span>
###xml 616 624 <span type="species:ncbi:9606">patients</span>
Upon our survey of clinicopathological correlations, UP recurred in 14.3% of the patients, but demonstrated no progression or association with PULC. IP was associated with LGPUC in 13.6% of the cases, but never progressed to LGPUC. PUNLMP showed two or more lesions in 13.6% of the cases, but all of the lesions were less than 1 cm. Of patients with PUNLMP, 18.2% demonstrated late recurrence (average 21.5 months) and 9.1% of the PUNLMP cases progressed to LGPUC in either 5 or 56 months. Of the patients with PULC, 70.4% (38/54) demonstrated a significantly higher frequency of recurrence and 9.3% (5/54) of these patients progressed to higher stage. With regard to the labile nomenclature and diagnostic criteria of PUNLMP, the biological behavior of PUNLMP remains controversial.
###end p 51
###begin p 52
###xml 15 17 15 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 268 269 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 710 712 710 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
Jordan et al. [13] concluded in a study of 91 cases with grade 1 urothelial tumors that low-grade lesions, usually designated transitional cell carcinoma, grade 1, are benign and should be called papilloma rather than carcinomas. In contrast, a study by Cheng et al. [6] of 112 PUNLMP cases found that those with PUNLMP are at risk of cancer progression and death from bladder cancer. Thus, it is prudent not to consider a constellation of low-grade papillary urothelial neoplasms to be benign. Pich et al. [18] studied 19 LMP cases and found that PUNLMP had a relatively high recurrence rate (47.4%) with no progression. These results were also in accordance with the study of 95 LMP cases by Holmang et al. [11]. We apparently observed that PUNLMP cases demonstrated late recurrences and progression with relatively lower frequencies, a finding that represents LMP. Statistical variations of recurrence and progression depend on many factors, including follow-up intervals, a definition of recurrence or progression, and sample size. However, reaching an accurate diagnosis may be most important. Therefore, we invented an algorithm by which a greater number of uniform diagnoses with less discrepancy can be achieved.
###end p 52
###begin p 53
In conclusion, the mitotic index and thickness of layers with cytologic atypia could be useful and reproducible parameters for the scoring algorithm to discriminate between papillary urothelial tumors. Based on the new scoring algorithm, PUNLMP can be clinicopathologically listed as an intermediary stage between UP and LGPUC.
###end p 53
###begin p 54
###xml 132 144 <span type="species:ncbi:9606">participants</span>
This study was supported by The Genitourinary Pathology Study Group of the Korean Society of Pathologists (2006). We appreciate all participants who screened and surveyed each case.
###end p 54
###begin p 55
###xml 0 30 0 30 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Conflict of interest statement</bold>
Conflict of interest statement We declare that we have no conflict of interest.
###end p 55
###begin title 56
References
###end title 56
###begin article-title 57
Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low grade papillary urothelial tumors. World Health Organization/International Society of Urologic Pathology
###end article-title 57
###begin article-title 58
Proliferation markers and DNA content analysis in urinary bladder TaT1 urothelial cell carcinomas: identification of subgroups with low and high stage progression risks
###end article-title 58
###begin article-title 59
Urothelial papillary (exophytic) neoplasm
###end article-title 59
###begin article-title 60
Atypia in inverted urothelial papillomas: pathology and prognostic significance
###end article-title 60
###begin article-title 61
The WHO/ISUP 1998 and WHO 1999 systems for malignancy grading of bladder cancer. Scientific foundation and translation to one another and previous systems
###end article-title 61
###begin article-title 62
Papillary urothelial neoplasms of low malignant potential. Clinical and biologic implications
###end article-title 62
###begin article-title 63
The Bladder Consensus Conference Committee (1999) The World Health Organization/International Society of Urologic Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder
###end article-title 63
###begin article-title 64
Evaluation of p53 protein overexpression, ki67 proliferative activity and mitotic index as markers of tumor recurrence in superficial transitional cell carcinomas of the bladder
###end article-title 64
###begin article-title 65
Expression of cytokeratin 20 redefines urothelial papillomas of the bladder
###end article-title 65
###begin article-title 66
Molecular pathology of non-invasive urothelial carcinomas
###end article-title 66
###begin article-title 67
Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy
###end article-title 67
###begin article-title 68
Papillary urothelial neoplasm of low malignant potential
###end article-title 68
###begin article-title 69
Transitional cell neoplasms of the urinary bladder: can biologic potential be predicted from histologic grading?
###end article-title 69
###begin article-title 70
Histopathological and immunohistochemical study of papillary urothelial neoplasm of low malignant potential and grade associated with extensive invasive low-grade urothelial carcinoma
###end article-title 70
###begin article-title 71
###xml 172 179 <span type="species:ncbi:9606">patient</span>
Interobserver discrepancy using the 1998 World Health Organization/International Society of Urologic Pathology Classification of urothelial neoplasm: practical choices for patient care
###end article-title 71
###begin article-title 72
Bladder cancer redefined
###end article-title 72
###begin article-title 73
Biologic difference between noninvasive papillary urothelial neoplasm of low malignant potential and low grade (grade 1) papillary carcinomas of the bladder
###end article-title 73
###begin article-title 74
Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasm of low malignant potential and grade 1 papillary carcinomas of the bladder
###end article-title 74
###begin article-title 75
The urothelial tract
###end article-title 75
###begin article-title 76
P53 and ki67 expression as prognostic factors for cancer-related survival in stage T1 transitional cell bladder carcinoma
###end article-title 76
###begin article-title 77
###xml 9 14 <span type="species:ncbi:9606">human</span>
Cultured human fibroblasts in agarose gel as a multi-functional control for immunohistochemistry. Standardization of Ki67 (MIB1) assessment in routinely processed urinary bladder carcinoma tissue
###end article-title 77
###begin article-title 78
Reproducibility of the 1998 World Health Organization/International Society of Urologic Pathology Classification of papillary urothelial neoplasms of the urinary bladder
###end article-title 78

